Protecting people with multiple sclerosis through vaccination

Saúl Reyes; Mary Ramsay; Shamez Ladhani; Gayatri Amirthalingam; Neena Singh; Carlos Cores; joela Mathews; Jonathan Lambourne; Monica Marta; Benjamin Turner; Sharmilee Gnanapavan; Ruth Dobson; Klaus Schmierer; G Giovannoni

doi:10.1136/practneurol-2020-002527

Article menu

Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts

PDF

Review

Protecting people with multiple sclerosis through vaccination

Free

Share this article

Click the icon of the social media platform on which you would like to share this article.

Share This Article:

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Protecting people with multiple sclerosis through vaccination

Message subject: (Your Name) has forwarded a page to you from Practical Neurology

Message body: (Your Name) thought you would like to see this page from the Practical Neurology web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Read the full text or download the PDF:

Log in using your username and password

For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?

Forgot your user name or password?

Other content recommended for you

Principles of immunisation in children with solid organ transplant
Chayarani Kelgeri et al., Archives of Disease in Childhood, 2020
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer et al., Annals of the Rheumatic Diseases, 2019
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
Tobias Monschein et al., Journal of Neurology, Neurosurgery & Psychiatry, 2021
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S van Assen et al., Annals of the Rheumatic Diseases, 2010
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
Marcia A Friedman et al., Annals of the Rheumatic Diseases, 2021
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
Christien Rondaan et al., RMD Open, 2019
Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
Susanne M A J Tielemans et al., BMJ, 2017
MMR vaccine - how effective and how safe?
, Drug and Therapeutics Bulletin, 2003
Two centuries of immunisation in the UK (part II)
Sarah Lang et al., Archives of Disease in Childhood, 2019
Vaccines and biologics
Isabel Ferreira et al., Annals of the Rheumatic Diseases, 2014

Log in using your username and password

Main menu

Log in using your username and password

You are here

Share this article

Email this article to a friend

Request permissions

Read the full text or download the PDF:

Log in using your username and password

Other content recommended for you